Jefferies on Boston Scientific (BSX): ICTx segment emerges as a double-digit growth engine
Tweet Send to a Friend
Jefferies analyst Matthew Taylor reiterated a Buy rating and $120.00 price target on Boston Scientific (NYSE: BSX)The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
